Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differentiated Thyroid Cancer, From Active Surveillance to Advanced Therapy: Toward a Personalized Medicine
Antonio Matrone, Maria Cristina Campopiano, Alice Nervo, et al.
Frontiers in Endocrinology (2020) Vol. 10
Open Access | Times Cited: 22

Showing 22 citing articles:

Recent Advances in Thyroid Cancer Research
Daniela Grimm
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4631-4631
Open Access | Times Cited: 34
Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer: Treatment Optimization for Maximum Clinical Benefit
Lori J. Wirth, Cosimo Durante, Duncan J. Topliss, et al.
The Oncologist (2022) Vol. 27, Iss. 7, pp. 565-572
Open Access | Times Cited: 26
Malignant and benign thyroid nodule differentiation through the analysis of blood plasma with terahertz spectroscopy
Maria Konnikova, О. П. Черкасова, М. М. Назаров, et al.
Biomedical Optics Express (2021) Vol. 12, Iss. 2, pp. 1020-1020
Open Access | Times Cited: 30
Targeting the Sonic Hedgehog Pathway to Suppress the Expression of the Cancer Stem Cell (CSC)—Related Transcription Factors and CSC-Driven Thyroid Tumor Growth
Yurong Lu, Yiwen Zhu, Shihan Deng, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 418-418
Open Access | Times Cited: 26
Clinical significance of oxidative stress markers as angioinvasion and metastasis indicators in papillary thyroid cancer
Angelika Buczyńska, Iwona Sidorkiewicz, Maria Kościuszko, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Plant natural products with anti-thyroid cancer activity
Javad Sharifi‐Rad, Sadegh Rajabi, Miquel Martorell, et al.
Fitoterapia (2020) Vol. 146, pp. 104640-104640
Closed Access | Times Cited: 23
Inhibition of the sonic hedgehog pathway activates TGF-β-activated kinase (TAK1) to induce autophagy and suppress apoptosis in thyroid tumor cells
Sumei Li, Jingxiang Wang, Yurong Lu, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 5
Open Access | Times Cited: 16
Management of Progressive Radioiodine-Refractory Thyroid Carcinoma: Current Perspective
Alice Nervo, Francesca Retta, Alberto Ragni, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 3047-3062
Open Access | Times Cited: 12
Thermal Ablation for Papillary Thyroid Microcarcinoma Located in The Isthmus: a Study With 3 Years Of Follow-Up
Lin Zheng, Fangyi Liu, Jie Yu, et al.
Future Oncology (2022) Vol. 18, Iss. 4, pp. 471-480
Closed Access | Times Cited: 10
Thyroglobulin Changes are Highly Dependent on TSH in Low-risk DTC Patients not Treated with Radioiodine
Antonio Matrone, Alessio Faranda, Francesco Latrofa, et al.
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 8, pp. e2845-e2852
Open Access | Times Cited: 12
Long-Term Outcomes and Prognoses of Elderly Patients (≥65-Years-Old) With Distant Metastases From Well-Differentiated Thyroid Cancer During Radioiodine Therapy and Follow-Up
Zhong‐Ling Qiu, Chen‐Tian Shen, Zhen‐Kui Sun, et al.
Frontiers in Endocrinology (2021) Vol. 11
Open Access | Times Cited: 11
Long-Term Outcome of Patients with Low-Risk Differentiated Thyroid Cancer Treated with Total Thyroidectomy Alone
Antonio Matrone, Alessio Faranda, Liborio Torregrossa, et al.
Current Oncology (2024) Vol. 31, Iss. 9, pp. 5528-5536
Open Access | Times Cited: 1
Multidisciplinary Canadian consensus on the multimodal management of high-risk and radioactive iodine-refractory thyroid carcinoma
Shereen Ezzat, Jesse D. Pasternak, Murali Rajaraman, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Role of Extracellular Vesicles in Thyroid Physiology and Diseases: Implications for Diagnosis and Treatment
Ophélie Delcorte, Jonathan Degosserie, Christophe E. Pierreux
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2585-2585
Open Access | Times Cited: 7
Electrical based cancer therapy for solid tumours - Theranostics approach
Mahalaxmi Iyer, Anila Venugopal, Mamatha Chandrasekhar, et al.
Biosensors and Bioelectronics X (2022) Vol. 11, pp. 100214-100214
Open Access | Times Cited: 5
Salvage surgery for cervical radioiodine refractory 18F-FDG-PET positive recurrence of papillary thyroid cancer
Costanza Chiapponi, Hakan Alakus, Michael Faust, et al.
Endocrine Connections (2021) Vol. 10, Iss. 9, pp. 1180-1188
Open Access | Times Cited: 6
Thyroid Cancer in the UAE
Riyad Bendardaf, Iman M. Talaat, Noha Mousaad Elemam, et al.
(2024), pp. 545-557
Open Access
Lenvatinib for the treatment of radioiodine-refractory differentiated thyroid cancer: treatment optimization for maximum clinical benefit
Lori J. Wirth, Cosimo Durante, Duncan J. Topliss, et al.
Head and neck tumors (HNT) (2023) Vol. 12, Iss. 4, pp. 81-90
Open Access | Times Cited: 1
BRAF K601E Mutation in Oncocytic Carcinoma of the Thyroid: A Case Report and Literature Review
Antonio Matrone, Fabrizia Citro, Carla Gambale, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 22, pp. 6970-6970
Open Access | Times Cited: 1
Is conservative management of the indeterminate thyroid nodule [Thy3f or Bethesda category IV] safe?
A. Gaunt, Alessandra Moore, C. Huvenne, et al.
European Archives of Oto-Rhino-Laryngology (2022) Vol. 279, Iss. 12, pp. 5905-5911
Closed Access | Times Cited: 1
Dynamin-2 and Angiopoietin-like protein 2 as novel prognostic markers in papillary thyroid carcinoma
Abeer M. Hafez, Abeer M. Abdelbary, Eman Elsebai, et al.
Zagazig University Medical Journal (2021)
Open Access | Times Cited: 1
Probiotic Bacteria Cannot Mitigate the Adverse Effects of Radioactive Iodine-131 Treatment
Seyed Mohammad Javad Mortazavi, Saba Nowroozi, Masoud Haghani, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 740-740
Open Access
Page 1

Scroll to top